NCT02544607View on ClinicalTrials.gov

Ketamine for Depression: An MRI Study

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 29, 2017

Study Completion Date

December 29, 2017

Conditions
DepressionAnxious DepressionMajor Depressive Disorder
Interventions
DRUG

Ketamine

Ketamine 0.5mg/kg over 40 minutes IV

OTHER

Magnetic Resonance Imaging (MRI)

MRI technology will be used before and after ketamine for patients with depression

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

Brain & Behavior Research Foundation

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Massachusetts General Hospital

OTHER